Medicine passport

OJJAARA 200 mg

The same active substance, strength and form as listed by each country’s medicines regulator. For showing a pharmacist abroad.

Active substance
Momelotinib (Momelotinib Dihydrochloride)
Strength
200 mg
Form
tablet
ATC code
L01EJ04
Registered in
Canada · Glaxosmithkline Inc
Prescription
Prescription only
DIN
02552981

Source: Drug Product Database · 2026-09-30

Not a prescription. Not a statement that these products are interchangeable. Products are matched on active substance, strength and kind of form only. Other ingredients, release, approved uses and the dose on the box can differ. A pharmacist or doctor decides whether one can replace another.

Listed in other countries

Spain 1 matching products

Name on the boxStrength and formPrescriptionHolderOfficial record
OMJJARA200 mg · comprimido recubierto con películaPrescription onlyGlaxosmithkline Trading Services Limited1231782003

Source: CIMA — Centro de Información online de Medicamentos (Agencia Española de Medicamentos y Productos Sanitarios (AEMPS)) · 2026-09-30 · Fuente: Agencia Española de Medicamentos y Productos Sanitarios (AEMPS), CIMA.

Netherlands 1 matching products

Name on the boxStrength and formPrescriptionHolderOfficial record
Omjjara 200 mg200 mg · filmomhulde tabletPrescription onlyGlaxoSmithKline Trading Services LimitedEU/1/23/1782

Source: Geneesmiddeleninformatiebank (College ter Beoordeling van Geneesmiddelen (CBG-MEB)) · 2026-09-30 · Bron: College ter Beoordeling van Geneesmiddelen (CBG). De Rijksoverheid is het niet automatisch eens met de inhoud van deze site.

Same active substance, but no match for this strength and form

Countries covered: United States, Bulgaria, European Union, Spain, France, Netherlands, Canada, Switzerland. A country missing from the list may still sell this medicine: Mediclarum reads only these registers.

Register data as of 2026-09-30. Mediclarum stores nothing about you for this page. https://www.mediclarum.com/ca/en/medicines/ojjaara-200-mg-tablet